ORIONISBIO

EUIPO EUIPO 2024 Application opposed

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark ORIONISBIO was filed as Word mark on 07/01/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application opposed".

Trademark Details Last update: January 17, 2025

Trademark form Word mark
File reference 019048225
Application date July 1, 2024
Publication date September 26, 2024

Trademark owner

950 Winter Street, Suite 4600
02451 Waltham
US

Trademark representatives

7 Rue Guimard 1040 Brussels BE

Objection / Complaint

12/23/2024: Likelihood of confusion Unfair advantage /detriment to distinctiveness or repute
Applicant
Orion Corporation

goods and services

1 Diagnostic, biological and chemical reagents for scientific and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; active chemical or biological ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases; cytokines, namely, reagents for scientific and research use
5 Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorder; pharmaceutical preparations, namely, cytokine inhibitory drugs; therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; biochemical and small molecule preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
42 Development of new technology for others in the field of biotechnology; scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; biotechnical research; technical consultation and research in the field of biotechnological research; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; research and development of pharmaceuticals for others; scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism

ID: 11019048225